COMMUNIQUÉS West-GlobeNewswire

Community Care Cooperative (C3) Earns $10.2 Million in Shared Savings Through Medicare Shared Savings Program (MSSP) Track A for Performance Year 2024
11/03/2026
BOSTON, March 11, 2026 (GLOBE NEWSWIRE) -- Community Care Cooperative (C3), the largest and most successful non-profit, FQHC-governed ACO in the country, announced today that it achieved $10.2 million in shared savings [...]
Lighter. Cheaper. Funner. Pub Light Is Here.
11/03/2026
Pub Beer introduces a 99‑calorie American‑style light lager at 4% ABV BEND, Ore., March 11, 2026 (GLOBE NEWSWIRE) -- Pub Beer , the Cheap Fun beer brand by Tilray Brands, Inc . (Nasdaq: TLRY; TSX: TLRY), today announced [...]
Arvinas to Present Phase 1 Data for ARV-102, a PROTAC LRRK2 Degrader, in Oral Session at the 2026 International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders
11/03/2026
– Company to highlight new safety, pharmacokinetic, and pharmacodynamic data from Phase 1 clinical trial of ARV-102 in participants with Parkinson’s disease – NEW HAVEN, Conn., March 11, 2026 (GLOBE NEWSWIRE) -- Arvinas [...]
Kamada Declares Cash Dividend of $0.25 Per Share, to be Paid in Accordance with an Adopted Annual Cash Dividend Policy
11/03/2026
Company Reports Record Revenue and Profitability for Full-Year 2025 REHOVOT, Israel and HOBOKEN, N.J., March 11, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company [...]
CRISPR Therapeutics Prices Upsized Convertible Senior Notes Offering
11/03/2026
ZUG, Switzerland and BOSTON, March 11, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics AG (Nasdaq: CRSP) (the “Company”) today announced the pricing of $550 million aggregate principal amount of its convertible senior [...]
Lexicon to Present Data on Effect of Kidney Function on the Long-term Efficacy and Safety of Sotagliflozin in Patients with Type 1 Diabetes at 19th International Conference on Advanced Technologies & Treatments for Diabetes
11/03/2026
Post hoc data analysis concluded that sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, improved glycemic control after one year in patients with normal and mildly reduced kidney function THE WOODLANDS, Texas, March 11, [...]
Ascentage Pharma to Report Full Year 2025 Unaudited Financial Results and Provide Business Updates on March 25, 2026
11/03/2026
ROCKVILLE, Md. and SUZHOU, China, March 11, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (Ascentage Pharma) (NASDAQ: AAPG; HKEX: 6855) (referred herein as “Ascentage Pharma,” the “Company,” “we,” “us” [...]
Verrica Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
11/03/2026
– YCANTH® net revenue grew 130% to $15.3 million in 2025, and selling, general and administrative expenses decreased by over 40%, when compared to 2024 – – Company earned $35.6 million in total revenue in 2025, up from [...]
Autonomix Medical to Present at LSI USA ’26
11/03/2026
THE WOODLANDS, TX, March 11, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today [...]
La Commission européenne approuve AKEEGA® (comprimé à double action de niraparib et d’acétate d’abiratérone) pour le traitement des patients atteints d’un cancer de la prostate hormonosensible métastatique (CPHSm) présentant des mutations BRCA1/2
11/03/2026
Le traitement par niraparib et acétate d’abiratérone démontre un retard cliniquement significatif dans la progression de la maladie, réduisant de près de moitié le risque de progression ou de décès, avec une tendance [...]
BrainsWay Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
11/03/2026
Q4 Revenue Grew 27% Year-Over-Year to Record $14.5 Million Q4 Operating Income of $1.9 Million; Adjusted EBITDA Increased by 53% to $2.3 Million, Reflecting Significant Operating Leverage Full Year 2025 Revenue [...]
Lifeward Regains Compliance with Nasdaq Minimum Bid Price Requirement
11/03/2026
HUDSON, Mass. and YOKNEAM ILLIT, Israel, March 11, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people [...]
Respiratory Medicine Publishes MATCH 2 Study Demonstrating Reliability of Real-Time Imaging Guidance in Robotic Bronchoscopy
11/03/2026
Study confirms 96.7% overall diagnostic yield due to precise lesion targeting using digital tomosynthesis and augmented fluoroscopy with CBCT verification SAN CARLOS, Calif., March 11, 2026 (GLOBE NEWSWIRE) -- Noah [...]
SCIENTURE Broadens Commercial Access for REZENOPY™, Highest-Dose FDA-Approved Naloxone Nasal Spray, Through GPO Agreements Reaching Over 5,000 U.S. Institutions
11/03/2026
Expands institutional footprint with potential penetration of more than ~ 60% of the U.S. market, while expanding reach across EMS providers and rehabilitation centers U.S. naloxone market totals $141M with 9.4 million [...]
Catheter Precision, Inc. Secures up to $88 Million in Strategic Institutional Financing Commitments to Fund Accelerated Growth
11/03/2026
Fully Funded Growth Strategy Supports Aircraft Fleet Expansion Providing Capacity to Service Current Demand in New Regions FORT MILL, S.C., March 11, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: [...]
Commit Biologics appoints serial biotech founder as new CEO to take complement-powered immune engagers into the clinic
11/03/2026
Dr. Thomas L. F. Montgomery Andresen joins from T-Cypher Bio Follows breakthrough non-human primate data demonstrating deep B-cell depletion without cytokine release Commit is poised to nominate its first two clinical [...]
Bavarian Nordic and Serum Institute of India Expand Strategic Partnership with Chikungunya Vaccine Manufacturing Agreement
11/03/2026
The agreement enables a full tech transfer of the chikungunya vaccine for future supply to low- and middle-income countries. Expanded collaboration provides future co-development opportunities. COPENHAGEN, Denmark, [...]
Propr® Introduces Propr Paste, Completing Its Clinically Inspired System for Gentle, Long-Term Oral Health
11/03/2026
New York, NY, March 11, 2026 (GLOBE NEWSWIRE) -- Propr ®, the fluoride free oral care brand founded by leading periodontist and educator Dr. Jack Gruber , today announced the launch of Propr Paste , the third product in [...]
Egg Medical présente les données CRT 2026 démontrant une voie responsable vers une protection légère sans plomb et sans tablier de plomb
11/03/2026
WASHINGTON, 11 mars 2026 (GLOBE NEWSWIRE) -- Egg Medical, leader dans le domaine des dispositifs de protection contre les rayonnements (ERPD), a annoncé aujourd’hui les résultats d’un essai de dernière minute présenté [...]

Pages